Development of NH101: a simple and efficient outpatient dry powder amphotericin b-dryneb(dry powder nebulizer) for treatment of susceptible and multidrug resistant aspergillus/ fungal infections
Ended Project Grant Awarded Last action
- Award ID
- R43HL147749
- Recipient
-
Nob Hill Therapeutics, Inc. UEI EL4UKHCBUCM3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,058
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- New Mexico, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $299,058 |
Quick answers
Who received award R43HL147749?
R43HL147749 was awarded to Nob Hill Therapeutics, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on February 15, 2020.
How much is award R43HL147749 worth?
$299,058 has been obligated on R43HL147749.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award